These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6977384)

  • 1. Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor.
    Bernard A; Murphy SB; Melvin S; Bowman WP; Caillaud J; Lemerle J; Boumsell L
    Blood; 1982 Mar; 59(3):549-54. PubMed ID: 6977384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathology of non-Hodgkin lymphomas.
    Huber H; Gattringer C; Knapp W; Stein H
    Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunologic phenotyping of cutaneous lymphomas].
    Kaudewitz P; Burg G; Smolle J; Braun-Falco O
    Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage.
    Ritz J; Nadler LM; Bhan AK; Notis-McConarty J; Pesando JM; Schlossman SF
    Blood; 1981 Sep; 58(3):648-52. PubMed ID: 6973348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
    Stein H
    Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia.
    Weiss LM; Bindl JM; Picozzi VJ; Link MP; Warnke RA
    Blood; 1986 Feb; 67(2):474-8. PubMed ID: 3080041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Ia-like antigen in lymphatic leukaemias and non-hodgkin lymphomas in correlation with other surface markers.
    Bergmann L; Mitrou PS; Cherdron T; Holloway K; Jost J; Timm V; Zerth G
    Scand J Haematol; 1982 Sep; 29(3):224-34. PubMed ID: 6983113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathology of cutaneous T-cell lymphomas.
    Nasu K; Said J; Vonderheid E; Olerud J; Sako D; Kadin M
    Am J Pathol; 1985 Jun; 119(3):436-47. PubMed ID: 3893149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides.
    Ralfkiaer E; Saati TA; Bosq J; Delsol G; Gatter KC; Mason DY
    J Clin Pathol; 1986 May; 39(5):553-63. PubMed ID: 3522633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells.
    Haynes BF; Metzgar RS; Minna JD; Bunn PA
    N Engl J Med; 1981 May; 304(22):1319-23. PubMed ID: 6971410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic and clinicopathologic features of common acute lymphoblastic leukemia antigen-positive childhood T-cell leukemia. A Pediatric Oncology Group Study.
    Dowell BL; Borowitz MJ; Boyett JM; Pullen DJ; Crist WM; Quddus FF; Russell EC; Falletta JM; Metzgar RS
    Cancer; 1987 Jun; 59(12):2020-6. PubMed ID: 2952260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunologic and clinicopathologic heterogeneity of cutaneous lymphomas other than mycosis fungoides.
    Wood GS; Burke JS; Horning S; Doggett RS; Levy R; Warnke RA
    Blood; 1983 Aug; 62(2):464-72. PubMed ID: 6603242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leu-M1 antigen expression in T-cell neoplasia.
    Wieczorek R; Burke JS; Knowles DM
    Am J Pathol; 1985 Dec; 121(3):374-80. PubMed ID: 3907362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of malignant and non-neoplastic cell phenotypes in highly malignant non-Hodgkin lymphomas.
    Porwit-Ksiazek A; Christensson B; Lindemalm C; Mellstedt H; Tribukait B; Biberfeld G; Biberfeld P
    Int J Cancer; 1983 Dec; 32(6):667-74. PubMed ID: 6317576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of human T lymphocytes: II. Phenotypic difference in skin and blood malignant T-cells in cutaneous T-cell lymphoma.
    Haynes BF; Hensley LL; Jegasothy BV
    J Invest Dermatol; 1982 Apr; 78(4):323-6. PubMed ID: 6121832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and hematological heterogeneity of T-cell derived lymphoproliferative diseases.
    Brouet JC; Flandrin G
    Bull Cancer; 1977; 64(2):267-74. PubMed ID: 143976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface markers in leukemia: biological and clinical correlations.
    Thiel E
    Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.